-
Sector Analysis
COVID-19: Contract Pharmaceutical Development and Manufacturing Relationships
This report examines contract manufacturing agreements for vaccines and therapies targeting COVID-19. It reports that there are more than 1,000 vaccines and therapies in development for COVID-19, and 36 vaccines and therapies approved (or granted emergency use authorization) for COVID-19 (as of report publication). At the beginning of the pandemic, slightly more than half of these agreements were for vaccines; this proportion has risen and continues to rise, as several vaccines have proven their safety and efficacy, received approval, and...
-
Product Insights
Genital Herpes Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H2, 2017" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital Herpes. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Edema Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Edema Global Clinical Trials Review, H2, 2017" provides an overview of Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hypocalcemia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hypocalcemia Global Clinical Trials Review, H2, 2017" provides an overview of Hypocalcemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypocalcemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Opioid Use Disorder: Opportunity Analysis and Forecasts to 2027
Opioid Use Disorder (OUD) is a chronic disorder that is described as the consequences associated with repeated, compulsive use of opioid drugs, and prolonged self-administration of opioid drugs. There are two subsets of patients that suffer from OUD; patients that become addicted to medical opioids, and patients that become addicted to non-medical opioids. There is no single cause of OUD, but rather a combination of genetic and environmental factors which influence the patient. Currently, there are a few drugs that...
-
Track & Monitor
CMO Scorecard – Outsourcing of NDA Approvals and CMO Performance – 2019 PharmSource Edition
This report is the 9th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance. CMO Scorecard is critical for benchmarking the performance of the CMO industry and the relative performance of major CMOs.
-
Track & Monitor
Contract Small Molecule API Manufacturing Industry by the Numbers – 2019 PharmSource Edition
This report characterizes the contract small molecule active pharmaceutical ingredient (API) manufacturing industry through a number of quantitative dimensions, including number and type of participants, containment and controlled substance capabilities, and financial performance of the top public contract manufacturing organizations (CMOs). Contract Small Molecule API Manufacturing is critical for establishing an understanding of the small molecule API CMO industry and the features of some of the largest CMOs participating in the industry.
-
Product Insights
Trichomonas Vaginitis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Trichomonas Vaginitis Global Clinical Trials Review, H2, 2018" provides an overview of Trichomonas Vaginitis clinical trials scenario. This report provides top line data relating to the clinical trials on Trichomonas Vaginitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Schistosomiasis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Schistosomiasis Global Clinical Trials Review, H2, 2018" provides an overview of Schistosomiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Schistosomiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Vasospastic Angina Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Vasospastic Angina Global Clinical Trials Review, H2, 2018" provides an overview of Vasospastic Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Vasospastic Angina. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...